You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Cholinergic receptor antagonist

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Postmenopausal Symptoms, Aging, Alzheimer Trial in Nashville, Burlington (Cholinergic antagonist)

Recruiting
  • Postmenopausal Symptoms
  • +2 more
  • Cholinergic antagonist
  • Nashville, Tennessee
  • +1 more
Mar 23, 2022

LARS - Low Anterior Resection Syndrome Trial in Seoul (Ramosetron)

Not yet recruiting
  • LARS - Low Anterior Resection Syndrome
  • Seoul, Jongro-gu, Korea, Republic of
    Seoul National University Hospital
Dec 13, 2022

Safety Issues, Pain, Pancreas Fibrosis Trial in Washington (Proglumide, Placebo)

Recruiting
  • Safety Issues
  • +2 more
  • Washington, District of Columbia
    Georgetown University
Dec 1, 2022

Monitoring Drug Efficacy in Patients With Alzheimer's Disease

Recruiting
  • Alzheimer Disease
  • AChE inhibitor monotherapy
  • AChE inhibitor and NMDA receptor antagonist combination therapy
  • Manila, Metro Manila, Philippines
    Philippine General Hospital
Mar 24, 2023

Prostate Cancer, Prostate Adenocarcinoma Trial (drug, other, procedure)

Not yet recruiting
  • Prostate Cancer
  • Prostate Adenocarcinoma
  • (no location specified)
Feb 2, 2023

Epidermolysis Bullosa Trial in Redwood City (Serlopitant Tablet, Placebo Oral Tablet)

Completed
Has Results
  • Epidermolysis Bullosa
  • Serlopitant Tablet
  • Placebo Oral Tablet
  • Redwood City, California
    Stanford University
Nov 30, 2022

Prostatic Tumors Trial in Beijing, NanJing, ShangHai (Apalutamide)

Active, not recruiting
  • Prostatic Neoplasms
  • Beijing, China
  • +3 more
Jan 17, 2023

Rectal Cancer Trial in Frankfurt (drug, radiation, procedure)

Recruiting
  • Rectal Cancer
  • Kineret 100 MG in 0.67 ML Prefilled Syringe
  • +3 more
  • Frankfurt, Germany
    University Hospital Goethe University Frankfurt
Aug 23, 2022

Sleep Initiation and Maintenance Disorders, Stress Disorders, Posttraumatic Trial in San Francisco, Salisbury (Suvorexant,

Recruiting
  • Sleep Initiation and Maintenance Disorders
  • Stress Disorders, Posttraumatic
  • San Francisco, California
  • +1 more
Nov 10, 2022

Acute Respiratory Distress Syndrome Trial in Montréal (Placebo, Ondansetron Injection)

Not yet recruiting
  • Acute Respiratory Distress Syndrome
  • Placebo
  • Ondansetron Injection
  • Montréal, Quebec, Canada
    Hôpital Sacré-Coeur de Montréal
Aug 22, 2022

Primary Aldosteronism, Hypertension Trial (Finerenone, Spironolactone)

Not yet recruiting
  • Primary Aldosteronism
  • Hypertension
  • (no location specified)
Apr 3, 2023

PTSD Trial in San Francisco (CORT108297, Placebo)

Not yet recruiting
  • PTSD
  • San Francisco, California
    San Francisco VA Medical Center, San Francisco, CA
Jul 26, 2022

Rotator Cuff Tendinitis, Chronic Pain Trial in Kristiansund (Ketalar, NaCl 9%)

Recruiting
  • Rotator Cuff Tendinitis
  • Chronic Pain
  • Kristiansund, Norway
    Department of Orthopedic Surgery, Kristiansund Hospital
Mar 15, 2022

Renal Cell Carcinoma Trial in Houston (Ipilimumab, Nivolumab, Ciforadenant)

Not yet recruiting
  • Renal Cell Carcinoma
  • Houston, Texas
    M D Anderson Cancer Center
Aug 11, 2022

COVID-19, SARS-CoV2 Infection Trial in India (Candesartan Cilexetil, Repagermanium, Candesartan Placebo)

Recruiting
  • COVID-19
  • SARS-CoV2 Infection
  • Candesartan Cilexetil
  • +3 more
  • Guntur, India
  • +4 more
Mar 13, 2022

Depressive Disorder, Major, Anxiety Disorder Trial (Nociceptin Receptor Antagonist, Aversive stimuli)

Not yet recruiting
  • Depressive Disorder, Major
  • Anxiety Disorder
  • Nociceptin Receptor Antagonist
  • Aversive stimuli
  • (no location specified)
Nov 3, 2022

Clinical Phenotypes in Pericarditis: IL-1RA Antibodies and suPAR

Not yet recruiting
  • Pericarditis
  • IL1RA Antibody Assay
  • suPAR Testing
  • Homburg, Germany
  • +8 more
Jun 22, 2023

Cardiovascular Diseases, Vascular Dilation Trial in Worcester (Ifetroban Sodium, Placebo)

Recruiting
  • Cardiovascular Diseases
  • Vascular Dilation
  • Ifetroban Sodium
  • Placebo
  • Worcester, Massachusetts
    University of Massachusetts Medical School
Feb 16, 2022

Steatohepatitis, Nonalcoholic Trial in Shibin Al Kawm (Control group, Montelukast group)

Completed
  • Steatohepatitis, Nonalcoholic
  • Control group
  • Montelukast group
  • Shibīn Al Kawm, Menoufia, Egypt
    Faculty of Medicine
Mar 15, 2022

Netosis During COVID-19, Under Treatment With

Active, not recruiting
  • Covid19
    • Paris, France
    • +1 more
    Mar 30, 2022

    Exercise, Histamine Trial in Ghent (Placebo: Placebo + exercise training., H1 blockade: H1 receptor antagonist + exercise

    Active, not recruiting
    • Exercise
    • Histamine
    • Placebo: Placebo + exercise training.
    • +2 more
    • Ghent, Oost-Vlaanderen, Belgium
      Department of movement and sports sciences, Ghent University, Be
    Nov 8, 2022

    Chronic Kidney Diseases Trial (Mineralocorticoid receptor antagonist, Placebo)

    Not yet recruiting
    • Chronic Kidney Diseases
    • Mineralocorticoid receptor antagonist
    • Placebo
    • (no location specified)
    Sep 21, 2023

    s to Learn More About Treatment With Steroidal Mineralocorticoid

    Active, not recruiting
    • Chronic Kidney Disease
    • +2 more
    • sMRA therapies
    • Whippany, New Jersey
      Many Locations
    Jan 30, 2023

    Type 2 Diabetes, Glucose Tolerance Impaired, Insulin Sensitivity Trial in San Antonio (REMD-477, Placebo Subcutaneous injection)

    Recruiting
    • Type 2 Diabetes
    • +2 more
    • San Antonio, Texas
      Texas Diabetes Institute
    Dec 22, 2021

    Spinal Cord Injuries, Myelopathy Trial in Cambridge (Istradefylline, low oxygen therapy)

    Not yet recruiting
    • Spinal Cord Injuries
    • Myelopathy
    • Cambridge, Massachusetts
      Spaulding Rehabilitation Hospital
    Jun 24, 2022